Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine
Clinical trial NCT03300050 · COMPLETED
Trial details
- NCT number
- NCT03300050
- Sponsor
- PATH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-10
- Primary completion
- 2018-04-24
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.